Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Management Strategies in Heart Failure
Anjali Owens, Susan C. Brozena, Mariell Jessup
Circulation Research (2016) Vol. 118, Iss. 3, pp. 480-495
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure
Shihui Fu, Ping Ping, Fengqi Wang, et al.
Journal of Biological Engineering (2018) Vol. 12, Iss. 1
Open Access | Times Cited: 165
Global left atrial failure in heart failure
Filippos Triposkiadis, Burkert Pieske, Javed Butler, et al.
European Journal of Heart Failure (2016) Vol. 18, Iss. 11, pp. 1307-1320
Open Access | Times Cited: 132
SERCA2a: a key protein in the Ca2+ cycle of the heart failure
Zhihao Liu, Jingyu Ni, Lan Li, et al.
Heart Failure Reviews (2019) Vol. 25, Iss. 3, pp. 523-535
Closed Access | Times Cited: 121
A perfusable, multifunctional epicardial device improves cardiac function and tissue repair
Shixing Huang, Dong Lei, Qi Yang, et al.
Nature Medicine (2021) Vol. 27, Iss. 3, pp. 480-490
Closed Access | Times Cited: 94
Cardiac Management of the Patient With Duchenne Muscular Dystrophy
Sujatha Buddhe, Linda Cripe, Joshua Friedland‐Little, et al.
PEDIATRICS (2018) Vol. 142, Iss. Supplement_2, pp. S72-S81
Open Access | Times Cited: 92
NEU1 Regulates Mitochondrial Energy Metabolism and Oxidative Stress Post-myocardial Infarction in Mice via the SIRT1/PGC-1 Alpha Axis
Zhen Guo, Di Fan, Fang-Yuan Liu, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 32
Molecular Mechanisms Responsible for Diastolic Dysfunction in Diabetes Mellitus Patients
Jovana Nikolajević Starčević, Miodrag Janić, Mišo Šabovič
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1197-1197
Open Access | Times Cited: 52
OPLAH ablation leads to accumulation of 5-oxoproline, oxidative stress, fibrosis, and elevated fillings pressures: a murine model for heart failure with a preserved ejection fraction
Atze van der Pol, Andrés Gil, Jasper Tromp, et al.
Cardiovascular Research (2018) Vol. 114, Iss. 14, pp. 1871-1882
Open Access | Times Cited: 47
Engineering highly-aligned three-dimensional (3D) cardiac constructs for enhanced myocardial infarction repair
Kang Han, Jiankang He, Li-Yan Fu, et al.
Biofabrication (2022) Vol. 15, Iss. 1, pp. 015003-015003
Closed Access | Times Cited: 17
Identification of the crucial roles of BAXhigh NK cells in human derived mesenchymal stem cell therapy for chronic heart failure patients
Pengfei Zhang, Yuanfeng Xin, Hui Yuan, et al.
Pathology - Research and Practice (2025), pp. 155924-155924
Closed Access
Pleiotropic mechanisms of action of perhexiline in heart failure
Christopher H. George, Alice N. Mitchell, Ryan Preece, et al.
Expert Opinion on Therapeutic Patents (2016) Vol. 26, Iss. 9, pp. 1049-1059
Open Access | Times Cited: 21
A risk prediction model for heart failure hospitalization in type 2 diabetes mellitus
Brent A. Williams, Daniela Geba, Jeanine M. Cordova, et al.
Clinical Cardiology (2019) Vol. 43, Iss. 3, pp. 275-283
Open Access | Times Cited: 20
Effect of heart failure reversal treatment as add-on therapy in patients with chronic heart failure: A randomized, open-label study
Rohit Sane, Abhijeet Aklujkar, Atul Patil, et al.
Indian Heart Journal (2016) Vol. 69, Iss. 3, pp. 299-304
Open Access | Times Cited: 19
Sacubitril/valsartan protects against arsenic trioxide induced cardiotoxicity in vivo and in vitro
Zhiqiang Wu, Hongzhu Chen, Liwang Lin, et al.
Toxicology Research (2022) Vol. 11, Iss. 3, pp. 451-459
Open Access | Times Cited: 11
Sacubitril/valsartan alleviates sepsis‐induced acute lung injury via inhibiting GSDMD‐dependent macrophage pyroptosis in mice
Jun Wang, Jierui Li, Anni Lou, et al.
FEBS Journal (2022) Vol. 290, Iss. 8, pp. 2180-2198
Closed Access | Times Cited: 11
Beneficial effects of paricalcitol on cardiac dysfunction and remodelling in a model of established heart failure
María Tamayo, Laura Martín‐Nunes, Almudena Val‐Blasco, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 14, pp. 3273-3290
Open Access | Times Cited: 16
Cardiovascular Pharmacology in Noncardiac Surgery
Liem P. Nguyen, Neal S. Gerstein
Elsevier eBooks (2019), pp. 247-288
Closed Access | Times Cited: 12
Ghrelin inhibited pressure overload–induced cardiac hypertrophy by promoting autophagy via CaMKK/AMPK signaling pathway
Weiwei Lu, Huaiqiu Cai, Yao Chen, et al.
Peptides (2020) Vol. 136, pp. 170446-170446
Closed Access | Times Cited: 11
Neprilysin Inhibition as a PARADIGM Shift in Heart Failure Therapy
Ruth Hsiao, Barry Greenberg
Current Heart Failure Reports (2016) Vol. 13, Iss. 4, pp. 172-180
Closed Access | Times Cited: 8
Efficacy of heart failure reversal treatment in patients with low ejection fraction
Rohit Sane, Mandole Rahul
Journal of Ayurveda and Integrative Medicine (2018) Vol. 9, Iss. 4, pp. 285-289
Open Access | Times Cited: 8
Rapid Repurposing of Novel Combination Drugs for the Treatment of Heart Failure via a Computationally Guided Network Screening Approach
Yunyuan Huang, Jiqun Wang, Jiaqi Liu, et al.
Journal of Chemical Information and Modeling (2021) Vol. 62, Iss. 21, pp. 5223-5232
Closed Access | Times Cited: 7
Enhanced Immunomodulation in Inflammatory Environments Favors Human Cardiac Mesenchymal Stromal-Like Cells for Allogeneic Cell Therapies
Falk Diedrichs, Meaghan Stolk, Karsten Jürchott, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 6
C-Type Natriuretic Peptide Improves Left Ventricular Functional Performance at Rest and Restores Normal Exercise Responses after Heart Failure
Tim Li, Hwai-Jong Cheng, Nobuyuki Ohte, et al.
Journal of Pharmacology and Experimental Therapeutics (2016) Vol. 357, Iss. 3, pp. 545-553
Open Access | Times Cited: 5
Heart failure
Derek G. Waller, Anthony P. Sampson
Elsevier eBooks (2017), pp. 131-142
Closed Access | Times Cited: 5
Applying the Seattle Heart Failure Model in the Office Setting in the Era of Electronic Medical Records
Brent A. Williams, Shikhar Agarwal
Circulation Journal (2018) Vol. 82, Iss. 3, pp. 724-731
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top